Synlett
DOI: 10.1055/s-0043-1775447
letter
Small Molecules in Medicinal Chemistry

Metal-Free Amidation and Selenoamidation of 2-Methylquinolines with Secondary Amines Using Selenium Dioxide, and Antibacterial Evaluation of the Products

Arbaz Sujat Shaikh
a   Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
,
Mahipal Singh Rathod
a   Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
,
Divya Vemula
b   Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
,
Priyanka N. Makhal
a   Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
C   Institute for Stem Cell Science and Regenerative Medicines (inStem), Bellary Road, Benguluru, Karnataka 560065, India
,
Vasundhara Bhandhari
b   Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
,
Venkata Rao Kaki
a   Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India
› Institutsangaben
All the authors are grateful to NIPER-Hyderabad for its facilities and to the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, for the award of a NIPER fellowship. V.R.K thanks ANRF, India, for funding (project no. EEQ/2023/001051).


Abstract

We report a metal-free protocol for the amidation and selenoamidation of 2-methylquinolines by using selenium dioxide as the key reagent. This method offers several advantages, including ease of operation, a short reaction time (15 min), and moderate to excellent yields (50–90%). The method demonstrates a broad substrate tolerance, including various secondary amines and 2-methyl heterocycles such as pyridine and benzothiazole. The applicability of the method was further highlighted through late-stage functionalization of ciprofloxacin, yielding a bioactive hybrid molecule with a remarkable MIC value of 0.195 μg/mL.

Supporting Information



Publikationsverlauf

Eingereicht: 18. November 2024

Angenommen nach Revision: 21. Januar 2025

Artikel online veröffentlicht:
06. März 2025

© 2025. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany